Abstract
There are hundreds of cosmetics and orally taken products not included as drugs in the market, even those that promise an additional therapeutic effect as lightening the skin, improving acne, and smoothing rhytides. The list of nutraceuticals is even greater especially when the so-called dietary supplements are included. There are numbers of papers and health alerts referring dangerous substances that are added to these products; some were exclusive from a specific country, but the globalization led to a mixture of all kinds of them being commercialized all around the world. Alerts should be taken seriously and the population should be also notified about this serious matter. We try to discuss about them, and although the list of substances is enormous and some adverse events yet to be described, it could be of interest to alert the patients about their choice. Each country has a list of forbidden formulations and chemicals; some are very rigorous and others still tolerant. We talk in this chapter the majority of them, but some of the regulatory issues are based in Brazilian ANVISA (National Health Department).
References
Agencia Nacional de Vigilância Sanitária. 1999. http://portal.anvisa.gov.br/wps/portal/anvisa/home
Berne B, Tammela M, Farm G, Inerot A, Lindberg M. Can the reporting of adverse skin reactions to cosmetics be proved? A prospective clinical study using a structured protocol. Contact Dermatitis. 2008;58:223–7.
Bons B, Audebret F, Bitaudeau C. Assessment of undesirable events in cosmetic market surveillance: background, description and use of a causality assessment method in cosmetovigilance. Regul Toxicol Pharmacol. 2010;58:349–53.
Di Giovanni C, Arcoraci V, Gambardella L, Sautebin L. Cosmetovigilance survey: are cosmetics considered safe by consumers? Pharmacol Res. 2006;53(1):16–21.
Dreno B, et al. The science of dermocosmetics and its role in dermatology. J Eur Acad Dermatol Venereol. 2014;28:1409–17.
Dureja H, Kaushik D, Kumar V. Developments in nutraceuticals. Indian J Pharm. 2003;35(6):363–72.
Instituto Nacional do Câncer. 2006. (http://www.inca.gov.br/conteudo_view.asp?ID=795) 16. U.S. National Institute of Cancer: http://www.cancer.gov/cancertopics/factsheet/Risk/formaldehyde.
International Agency for Research Organization. IARC Monographs Carcinogenic Risks to Humans. 2006;88. http://monographs.iarc.fr/ENG/Monographs/vol88/index.php.
International Programme on Chemical Safety (IPS): Chemical Safety Information from Intergovernmental Organizations (INCHEM). 1993. http://www.inchem.org/documents/sids/sids/57136.pdf; http://www.inchem.org/documents/jecfa/jeceval/jec_2374.htm; http://www.inchem.org/documents/icsc/icsc/eics0595.htm.
Krasteva M, et al. Contact allergy to hair colouring products – the cosmetovigilance experience of 4 companies (2003–2006). Eur J Dermatol. 2010;20(1):85–95.
Krecisz B, Chomiczewska-Skóra D, Kiec-Swierczynska M. Preservatives as important etiologic factor of allergic contact dermatitis. Med Pr. 2015;66(3):327–32. doi:10.13075/mp.5893.00176.
Lefebvre MA, Meuling WJ, Engel R, Coroama MC, Renner G, Pape W, Nohynek GJ. Consumer inhalation exposure to formaldehyde from the use of personal care products/cosmetics. Regul Toxicol Pharmacol. 2012;63(1):171–6. doi:10.1016/j.yrtph. 2012.02.011. Epub 3 Mar 2012.
Moretti U, Velo G. Cosmetovigilance: the ‘beautiful’ risk. Drug Saf. 2008;31(5):437–9.
National Toxicology Program, Department of Health and Human Services. Services Report on Carcinogens, Twelfth Edition. 2011. Formaldehyde (CAS N. 50–00-0): http://ntp.niehs.nih.gov/ntp/roc/twelfth/profiles/Formaldehyde.pdf
Nohynek GJ, Antignac E, Re T, Toutain H. Safety assessment of personal care products/cosmetics and their ingredientes. Toxicol Appl Pharmacol. 2010;243:239–59.
Pauwels M, Rogiers V. Human health safety evaluation of cosmetics in the EU: a legally imposed challenge to science. Toxicol Appl Pharmacol. 2010;243(2):260–74.
Salverda J, et al. Results of a cosmetovigilance survey in the Netherlands. Contact Dermatitis. 2013;68:139–48.
Sautebin L. A cosmetovigilance survey in Europe. Pharmacol Res. 2007;55(5):455–60.
U.S. Department of Labor. Occupational Safety and Health Administration. 2011. http://www.osha.gov/SLTC/formaldehyde/index.html.
Vigan M, Castelain F. Cosmetovigilance: definition, regulation and use “in practice”. Eur J Dermatol. 2014;24(6):643–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this entry
Cite this entry
Notaroberto, P., Tamura, B.M. (2017). Issues Concerning Safety of Topical Cosmetics and Nutraceuticals. In: Issa, M., Tamura, B. (eds) Daily Routine in Cosmetic Dermatology. Clinical Approaches and Procedures in Cosmetic Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-20250-1_28-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-20250-1_28-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20250-1
Online ISBN: 978-3-319-20250-1
eBook Packages: Springer Reference MedicineReference Module Medicine